title: Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance program.
authors.forename: M R
authors.initials: MR
authors.lastname: Naef
authors.forename: H C
authors.initials: HC
authors.lastname: Bucher
authors.forename: P
authors.initials: P
authors.lastname: Erb
authors.forename: N
authors.initials: N
authors.lastname: Gyr
authors.forename: S
authors.initials: S
authors.lastname: Bassetti
authors.forename: M
authors.initials: M
authors.lastname: Battegay
mesh_terms: D000328:Adult; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000517:prevention & control* / Q000635:transmission; D015528:HIV Seroprevalence / Q000639:trends; D006506:Hepatitis A / Q000150:complications / Q000517:prevention & control* / Q000635:transmission; D006509:Hepatitis B / Q000150:complications / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000008:administration & dosage*; D009313:National Health Programs; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000628:therapy*; D013557:Switzerland / Q000453:epidemiology
chemical_list: D009294:Narcotics